SCHEMBL5680285

SCHEMBL5680285

CC(C)c1ccccc1-c1ccccc1PC1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
PTPRC P08575 1/20 0.33
PTPRF P10586 1/20 0.33
CDC25B P30305 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
DPP4 P27487 1/20 0.31
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
AXL P30530 1/20 0.31
DHFR P00374 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL648482 0.85 BCHE (0.37) PTPN1ALDH1A1LMNAPTPRCPTPRF
SCHEMBL29169833 0.83 PTPN1 (0.37) PTPN1ALDH1A1LMNAPTPRCPTPRF
SCHEMBL31633552 0.81 PTPRC (0.30) PTPN1PTPRCPTPRFCDC25B
SCHEMBL664617 0.81 ROCK2 (0.44) PTPN1PTPRCPTPRFCDC25B
SCHEMBL30587348 0.76 PTPRC (0.32) PTPN1PTPRCPTPRFCDC25B
SCHEMBL1068168 0.75 HTR6 (0.33) ALDH1A1LMNA
SCHEMBL18323806 0.75 SMN1; SMN2 (0.43) PTPN1LMNAPTPRC
SCHEMBL29732924 0.75 HTR6 (0.33) ALDH1A1LMNA
SCHEMBL4739711 0.75 CA12 (0.42) ALDH1A1LMNACA12CA1CA2
SCHEMBL3954820 0.75 ALDH1A1 (0.41) ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1636160-A4 NOVEL THERAPEAUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLIC DISEASES AND SKIN DISORDERS AUSPEX PHARMACEUTICALS (US) 2006-09-27 EP disclosed
EP-1636160-A2 NOVEL THERAPEAUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLIC DISEASES AND SKIN DISORDERS Auspex Pharmaceuticals (US) 2006-03-22 EP disclosed
WO-2005000233-A2 NOVEL THERAPEAUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLIC DISEASES AND SKIN DISORDERS AUSPEX PHARMACEUTICALS (US) 2005-01-06 WO disclosed